Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 83.42
-4.8 %
$ 8.84 B
Market Cap
-100.51
P/E
Price Target
Average
13.42%
Revenue Forecast
Estimate
54.09%
EBIT
Estimate
--94.36%
Net Income
Estimate
77.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Intra-Cellular Therapies, Inc.
Wall Street analysts predict an average 1-year price target for ITCI of $94.6 , with forecasts ranging from a low of $74 to a high of $107 .
ITCI Lowest Price Target
Wall Street Target
74 USD
-11.29%
ITCI Average Price Target
Wall Street Target
94.6 USD
13.42%
ITCI Highest Price Target
Wall Street Target
107 USD
28.27%
REVENUE FORECAST
Revenue Forecast Chart ITCI
EBIT FORECAST
EBIT Forecast Chart ITCI
NET INCOME FORECAST
Net Income Chart ITCI